Aspen Grove Capital’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.94M Sell
18,676
-7,533
-29% -$802K 0.38% 42
2025
Q4
$2.7M Buy
26,209
+186
+0.7% +$18.1K 0.47% 37
2025
Q3
$2.35M Buy
26,023
+179
+0.7% +$15.7K 0.4% 37
2025
Q2
$2.27M Buy
25,844
+150
+0.6% +$13K 0.39% 40
2025
Q1
$2.34M Hold
25,694
0.45% 38
2024
Q4
$2.22M Buy
25,694
+233
+0.9% +$21.1K 0.47% 37
2024
Q3
$2.42M Buy
25,461
+100
+0.4% +$9.5K 0.53% 33
2024
Q2
$2.32M Buy
25,361
+151
+0.6% +$13.5K 0.55% 32
2024
Q1
$2.29M Sell
25,210
-1
-0% -$88 0.65% 29
2023
Q4
$2.05M Buy
25,211
+204
+0.8% +$16K 0.62% 32
2023
Q3
$2M Buy
25,007
+126
+0.5% +$10.2K 0.74% 31
2023
Q2
$1.96M Buy
24,881
+208
+0.8% +$16.3K 0.63% 31
2023
Q1
$1.92M Hold
24,673
0.84% 27
2022
Q4
$1.92M Buy
+24,673
New +$1.82M 0.89% 27

Other funds holding PPH